ZIMMER BIOMET HOLDINGS, INC. 4
4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Dec 5, 2016
Insider Transaction Report
Form 4
Nolan David A. Jr.
Group President
Transactions
- Sale
Common Stock
2016-12-02$101.11/sh−5,050$510,619→ 7,989 total - Exercise/Conversion
Common Stock
2016-12-01+5,050→ 13,039 total - Exercise/Conversion
Restricted Stock Units
2016-12-01−5,050→ 0 total→ Common Stock (5,050 underlying)
Footnotes (5)
- [F1]Includes 1 share acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between August 1, 2016 and October 31, 2016, 5 shares purchased on October 28, 2016 under the dividend reinvestment plan for the Company's common stock, and 9 shares acquired between August 1, 2016 and October 31, 2016 through dividend reinvestment in Mr. Nolan's IRA.
- [F2]Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Nolan on November 3, 2016.
- [F3]Represents the sale of 5,050 shares in multiple transactions, ranging in price from $101.01 to $101.24 per share, resulting in a weighted average sale price of $101.1126. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F4]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
- [F5]The RSUs vested on December 1, 2016.